Siglec-6 is a target for chimeric antigen receptor T-cell treatment of chronic lymphocytic leukemia
Damián Kovalovsky, Jeong Heon Yoon, Matthew G. Cyr, Samantha Simon, Elisaveta Voynova, Christoph Rader, Adrian Wiestner, Julie Alejo, Stefania Pittaluga, Ronald E. Gress
Topics & Concepts
Chimeric antigen receptorSIGLECChronic lymphocytic leukemiaCD19AntigenCancer researchStem cellImmunologyHaematopoiesisLeukemiaBiologyImmunotherapyImmune systemCell biologyCAR-T cell therapy researchChronic Lymphocytic Leukemia ResearchLymphoma Diagnosis and Treatment